Cardiovascular toxicity profile of doxorubicin: data mining of the FDA adverse event reporting system (FAERS)

Abstract Funding Acknowledgements None. Background Doxorubicin (DOX), an effective anticancer agent, is associated with dose-dependent cardiovascular toxicity. Understanding its mechanisms and risk factors will facilitate novel interventions to minimize DOX-induced cardiovascular toxicity. Purpose W...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cardiovascular research 2024-05, Vol.120 (Supplement_1)
Hauptverfasser:	Kattan, L, Cerbito, E, Dhulkifle, H, Korashy, H, Maayah, Z
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!